H5N1 Bird Flu Threat: Experts Sound Alarm Over Potential Pandemic As Infections Spread To All 50 US States
The latest data also revealed that there are "ongoing mutations" across the circulating avian influenza viruses
The warning comes as the HHS pursues an overhaul of the US public health system
Virology experts from across 40 countries have sounded the alarm over the rising threat of H5N1 avian flu, a subtype of the influenza A virus that causes respiratory disease in birds (avian influenza or bird flu), and has now affected humans too.
In a commentary published this week in the medical journal The Lancet Regional Health – Americas, top virologists warned of the recent emergence of "highly pathogenic" H5N1 infections not only in dairy cows, but also in humans in the U.S.
Dozens of individuals affected: Virologists
According to the virologists, there have been over 995 dairy cows and at least 70 humans affected by the virus infections, including a severe case that became the "first reported H5N1-related death in the U.S."
The infections were recorded from 2024 through April 2025, "with the epizootic now present in all 50 states and human cases in 13 states and Canada."
They also cited a February report by the Centers for Disease Control and Prevention (CDC) that highlighted increased evidence of the virus's transmission to people.
"While the H5N1 outbreak in dairy cows and associated farm workers has not resulted in sustained human-to-human transmission, the possibility of virus adaptation and widespread infections requires proactive and vigilant measures," they pointed out.
They also urged leaders not just in the United States, but across the world, to improve preventive measures by utilizing all the knowledge painfully learned during the COVID-19 pandemic.
Evidence shows the virus is mutating
Aside from a growing number of people getting infected with the virus, sequencing data from circulating avian influenza viruses suggest "ongoing mutations and reassortment/mixing of genomic segments."
The widespread viral circulation has apparently affected not only dairy cows, but also other mammal species, including suspected cases in sea lions and minks.
"In mammals, these viruses may acquire mutations that increase their ability to transmit and replicate efficiently in mammals, eventually including humans," they warned, though they noted that such cases have yet to be demonstrated.
How worried should Americans be?
The virologists explained that in the past human H5N1 infections were primarily from bird-to-human transmission. However, recent data indicated that the situation had changed.
Furthermore, the proportion of undiagnosed human infections is currently unknown, which further raises the risk of exposure and eventual infection.
According to the experts, the following can play a role in the transmission of H5N1 to humans: Contaminated poultry products
Improper pasteurization and improper cooking of poultry and dairy products
Handling of infected poultry or cows
Direct contact with products from infected cows or poultry
Domestic pets that consume infected birds
The experts have urged leaders to improve various measures to prevent the bird flu's spread, including for biosecurity and biocontainment in farms, as well as awareness campaigns to keep the public informed about the avian influenza.
Warning comes at critical time in federal government
The virology warning comes at a time when concerns are rife over the Department of Health and Human Services (HHS), which recently saw staff reductions across a wide range of professionals, including researchers and medical experts.
The layoffs reportedly included some staff members of the U.S. Food and Drug Administration (FDA) who worked on the agency's response to the bird flu.
Despite the potential for a bird flu pandemic, Health Secretary Robert F. Kennedy Jr. seems committed to his initiative of overhauling the public health system and dismantling institutions he deems are not critical.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
DW
2 days ago
- DW
Fraudulent research is 'destroying trust in science' – DW – 08/10/2025
Organized networks are infiltrating the academic publishing system to promote fake science, say experts investigating research fraud. A new study highlights the major challenge for modern science. Fraudulent scientific research is on the rise and is jeopardizing medical research, experts have warned. A new study has found that networks of bad actors work together to publish bogus research. The findings, published in the journal this week, came from analyzing more than 5 million scientific articles published across 70,000 journals. "There are groups of editors conspiring to publish low-quality articles, at scale, escaping traditional peer review processes," said the study's lead author Reese Richardson, a social scientist at Northwestern University in the US. The research uncovered evidence of networks of scientific journal editors who frequently publish research that is flagged for integrity issues, and "brokers" who connect fraudulent authors to these editor networks. "This kind of fraud destroys trust in science. It biases systematic and meta-analysis, it delays treatment and delays new research," said Anna Abalkina, a social scientist at the Free University of Berlin, who was not involved in the study. New scientific research is published as research papers in research journals. There are tens of thousands of different research journals, each publishing different themes of research, and with different levels of scientific impact. These journals are platforms for researchers to share their findings, theories and ideas with peers and the broader public. "Historically, the scientific [publication] enterprise has been an engine for progress. It's given us vaccines, antibiotics, the internet, sterile surgery … everything that makes life comfortable for us now," said Richardson. But sham research is on the rise — as many as one in seven research publications contain fake data, by some estimates. Artificial intelligence is also fueling this research misconduct. Fraudulent studies contain fabricated data, unverified results, plagiarized research or manipulated images. "You can map out networks of image duplication that are thousands of articles wide," Richardson said. Fake or poor-quality research is typically caught by journal editors or peer reviewers, but experts warn it is increasingly making its way to publication by groups of bad actors working together. Several high-profile instances of scientific fraud have been uncovered. During the COVID-19 pandemic, fraudulent research was used to make scientific and political judgments on the merits of hydroxychloroquine as a treatment for COVID infection. Experts linked the issue with "self-promotion journals" — where publication authors are often the editors of the very same journals in which they publish their studies. Even single fraudulent studies can cause lasting problems. For example, researchers found evidence of image manipulation in a landmark study about Alzheimer's disease. The paper was eventually retracted and the lead scientist resigned, but Abalkina said billions of dollars in research funding and years of research had already been invested from one bad study. "[It's] incredible what just one paper can do," Abalkina told DW. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video The study's senior author Luis Amaral of Northwestern University said it was "probably the most depressing project I've been involved with." "It's distressing to see others engage in fraud and in misleading others. But if you believe that science is useful and important for humanity, then you have to fight for it," Amaral said. Scientific publishing groups are aware of the issue and are working to create new methods to identify and retract fraudulent research. One major publisher, Springer Nature, retracted 2,923 articles from its publications in 2024. But retracting papers means that bad science has already made it to publication. Experts like Abalkina and Richardson said the issues ultimately come from how scientific research is valued. Scientific jobs and funding are dependent on scientific publication. "Where you're faced with a [lack] of resources and yet you're pressured to put out [publications], you're left with two options really: You either buy into scientific fraud, or your leave science. This is a situation that tens of thousands of scientists are in," said Richardson. That's why the best solution to fight fraudulent publications, he said, is to ditch all quantitative metrics of research assessment like counting publications and citations.
DW
6 days ago
- DW
Experts alarmed by US cuts to mRNA vaccine research – DW – 08/08/2025
US Health Secretary Robert F. Kennedy Jr. has slashed government spending on mRNA vaccine research. Experts warn it will boost global vulnerability to future pandemics. The first signs of an overhaul came quickly from the newly inaugurated US President Donald Trump. After being back in power just two months, his administration had already slashed funding for more than 30 research projects related to reasons for and measures against vaccine skepticism. This made it clear to scientists that future mRNA research in the US could also be in jeopardy. At that time, the administration of the National Institutes of Health (NIH), which is responsible for biomedical research, had also requested a list of all NIH-funded research projects dealing with mRNA technology. These were to be forwarded to the Department of Health and Human Services and the White House. A similar request was also made regarding research projects related to vaccine skepticism — before their funding was cut. This week, the Department of Health and Human Services — headed by Health Secretary Robert F. Kennedy Jr., who is known for his opposition to vaccines — announced it would cut $500 million in research funding for mRNA vaccines at the NIH. A statement from the Department of Health and Human Services (HHS) said it would terminate several contracts, reject applications for research funding that had already been submitted and restructure some existing partnerships. "We reviewed the science, listened to the experts, and acted," said Kennedy. Investment in 22 projects dealing with mRNA vaccines will be halted "because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu." But experts immediately took issue with his statement. They point out that mRNA vaccines have been used successfully in the COVID pandemic. "Overall mRNA vaccines were responsible for saving millions of lives in the COVID-19 pandemic," said Charles Bangham, professor emeritus of immunology at Imperial College London. "Few, if any, antiviral vaccines will completely prevent the virus from entering the body," Bangham continued. "What the vaccine does is to lessen the severity of the infection, reducing disease and the risk of death." Jaime M. Yassif of the Nuclear Threat Initiative (NTI), a nonprofit organization that campaigns against biological, nuclear and chemical weapons, called the announced funding cuts "a grave mistake." "Halting research on much needed technology for rapidly developing new vaccines makes Americans and the world vulnerable to future pandemics," said Yassif, vice president for biological policy and programs at NTI, in a statement. This applies to both naturally occurring diseases and those that could be developed in a laboratory and used as weapons, she added. Kennedy's claim that mRNA vaccines do not offer reliable protection "is patently false," Yassif said. "If not for the rapid deployment of mRNA vaccines during COVID-19, the cost in lives lost and economic damage would have been far more severe." The German company BioNTech, which developed one of the mRNA coronavirus vaccines in collaboration with the US pharmaceutical company Pfizer, is not affected by the cuts. "We have not received any funds from the US government and have nothing outstanding," a BioNTech spokeswoman told DW. In contrast, cooperation partner Pfizer is mentioned in the HHS' statement under the heading "rejection or cancellation" of proposals. Pfizer shares temporarily lost 3% of their value after Kennedy's decision was announced. The company did not respond to a request for comment from DW. The renowned Emory University in the US state of Georgia is also among those whose contracts with the US government are being wound up. A spokesperson for the university's Woodruff Health Sciences Center told DW that the cutbacks affect a research project involving a drug for the treatment of respiratory diseases such as influenza and COVID-19. The collaboration had only been announced in September 2024. Emory University researchers were planning to test whether the antiviral treatment could be produced as a dry powder that would not require continuous cooling. The funds for this project have now been cut. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video The mRNA technology is not only used in vaccines against respiratory diseases. From acne to Lyme disease and dengue fever to AIDS, researchers are looking for mRNA vaccines against a wide variety of diseases. Research is being conducted all over the world, with China and South Korea among the countries working on many projects. The technology also plays an important role in cancer research. In the fight against colon cancer, for example, US researchers are working on a drug that is intended to prevent the cancer from returning after the original tumor has been surgically removed. According to the HHS, funding for such research should be maintained. However, experts are calling for continued support for mRNA vaccine research as well. Cuts in research would limit the US' ability to develop vaccines quickly in the event of a new pandemic, unless "alternative sources of funding can be secured," said Penelope Ward, visiting professor of pharmaceutical medicine at King's College London. Furthermore, she added, the cuts are not just a problem for the US. "It is detrimental to us all."
DW
6 days ago
- DW
Experts alarmed by US cuts to mRNA vaccine research
US Health Secretary Robert F Kennedy Jr has slashed US government spending on mRNA vaccine research. Experts warn it will boost our vulnerability to future pandemics. The first signs of an overhaul came quickly from the newly inaugurated US president Donald Trump. After being in power just two months, his administration had already slashed funding for more than 30 research projects relating to vaccine skepticism. This made it clear to scientists that future mRNA research in the US could also be in jeopardy. At that time, the administration of the National Institutes of Health (NIH) had also requested a list of all NIH-funded research projects dealing with mRNA technology. These were to be forwarded to the Department of Health and Human Services and the White House. A similar request had also been made regarding research projects on vaccine skepticism — before their funding was cut. This week, the US Department of Health and Human Services announced that it would cut $500 million in research funding for mRNA vaccines. The NIH is an agency of the US Department of Health and Human Services responsible for biomedical research. It is headed by US Health Secretary Robert F. Kennedy Jr., who is known for his opposition to vaccines. How effective are mRNA vaccines? A statement from the Department of Health and Human Services said it would terminate several contracts, reject applications for research funding that had already been submitted, and restructure some existing partnerships. "We reviewed the science, listened to the experts, and acted," said Health Secretary Kennedy. Investment in 22 projects dealing with mRNA vaccines will be halted "because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu." US Health Secretary Kennedy is a well-known opponent of vaccination and supports the disproved theory that vaccinations can cause autism Image: Morry Gash/AP Photo/File/picture alliance But experts immediately took issue with his statement. They point out that mRNA vaccines have been used successfully in the coronavirus pandemic. "Overall mRNA vaccines were responsible for saving millions of lives in the COVID-19 pandemic," said Charles Bangham, professor emeritus of immunology at Imperial College London. "Few, if any, anti-viral vaccines will completely prevent the virus from entering the body," Bangham continued. "What the vaccine does is to lessen the severity of the infection, reducing disease and the risk of death." Slowing mRNA research leaves us 'more vulnerable to future pandemics' Jaime M. Yassif of the Nuclear Threat Initiative (NTI), a non-profit organization that campaigns against biological, nuclear, and chemical weapons, called the announced funding cuts "a grave mistake." 'Halting research on much needed technology for rapidly developing new vaccines makes Americans and the world vulnerable to future pandemics,' said Yassif, vice president for biological policy and programs at NTI, in a statement. This applies to both naturally occurring diseases and those that could be developed in a laboratory and used as weapons, he added. Health Secretary Kennedy's claim that mRNA vaccines do not offer reliable protection "is patently false," Yassif said. "If not for the rapid deployment of mRNA vaccines during COVID-19, the cost in lives lost and economic damage would have been far more severe." Pharmaceutical company Pfizer shares down on cuts The German company BioNTech, which developed one of the mRNA coronavirus vaccines in collaboration with the US pharmaceutical company Pfizer, is not affected by the cuts. "We have not received any funds from the US government and have nothing outstanding," a BioNTech spokeswoman told DW. In contrast, cooperation partner Pfizer is mentioned in the Health Ministry's statement under the heading "rejection or cancellation" of proposals. Pfizer shares temporarily lost 3% of their value after Kennedy's decision was announced. The company did not respond to a request for comment from DW. The renowned Emory University in the US state of Georgia is also among those whose contracts with the US government are being wound up. A spokesperson for the university's Woodruff Health Sciences Center told DW that the cutbacks affect a research project involving a drug for the treatment of respiratory diseases such as influenza and COVID-19. The collaboration had only been announced in September 2024. Emory University researchers were planning to test whether the antiviral treatment could be produced as a dry powder that would not require continuous cooling. The funds for this project have now been cut. What's in store for mRNA technology after COVID? Research cuts impact beyond the US The mRNA technology is not only used in vaccines against respiratory diseases. From acne to Lyme disease and dengue fever to AIDS, researchers are looking for mRNA vaccines against a wide variety of diseases. Research is being conducted all over the world, with China and South Korea among the countries working on many projects. The technology also plays an important role in cancer research. In the fight against colon cancer, for example, US researchers are working on a drug that is intended to prevent the cancer from returning after the original tumor has been surgically removed. According to the US Department of Health and Human Services, funding for such research should be maintained. However, experts are calling for continued support for mRNA vaccine research as well. Cuts in research would limit the US's ability to develop vaccines quickly in the event of a new pandemic, unless "alternative sources of funding can be secured," says Penelope Ward, visiting professor of pharmaceutical medicine at King's College London. Furthermore, she added, the cuts are not just a problem for the US. "It is detrimental to us all." This article originally appeared in German.
